Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03796065 · ClinicalTrials.gov registry record · NA

Addressing Mental Health Disparities in Refugee Children

A NA study, sponsored by Boston College.

Completed
Registry status
NA
Development phase
354
Enrollment target

NCT03796065: Completed NA study, sponsored by Boston College.

NCT03796065 is a NA study that has completed, run by Boston College. The registered enrollment target is 354 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03796065, a NA study, has completed, sponsored by Boston College.

COMPLETED
Registry status
NA
Development phase
354 participants
Enrollment target

Study Summary

The proposed study will employ a cross-cultural Community Based Participatory Research (CBPR) approach to build from prior needs assessments and mixed-methods research to evaluate the effectiveness of the Family Strengthening Intervention for Refugees (FSI-R), a preventative family home-based visiting intervention intended to mitigate mental health disparities among refugee children and families using a hybrid implementation-effectiveness design. Results of the investigator's trial will expand the evidence-base on community-based interventions for refugees and has the potential to be replicated to reduce mental health disparities affecting diverse groups of refugee children and families.

Primary Outcome

The Family Conflict Scale utilizes a 7-point Likert Scale (0-6) to assess family conflict within the past month. Higher scores reflect greater family conflict.

Interventions

  • BEHAVIORAL FSI-R Treatment

Trial Details

FieldValue
Enrollment Target 354 participants
Start Date 2018-08-27
Est. Completion 2022-06-30
Phase NA
Boston College

18 total trials

What the finished NCT03796065 record still lists

NCT03796065 is an interventional study that assigns participants to a tested intervention. The registered 354 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 1 intervention - of which FSI-R Treatment is the first listed.

NCT03796065 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03796065 about?

NCT03796065 is a clinical study titled "Addressing Mental Health Disparities in Refugee Children". The proposed study will employ a cross-cultural Community Based Participatory Research (CBPR) approach to build from prior needs assessments and mixed-methods research to evaluate the effectiveness of the Family Strengthening Intervention for Refugees (FSI-R), a preventative family home-based visiti...

What is the current status of trial NCT03796065?

This trial is currently completed. It is a NA study. The enrollment target is 354 participants. The study started on 2018-08-27. Estimated completion is 2022-06-30.

What interventions are being tested in trial NCT03796065?

The interventions under investigation include: FSI-R Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT03796065?

This trial is sponsored by Boston College, which has 18 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03796065's enrollment target sits among peer trials

354 291st of 2000 higher than 1,709 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02579967 · 354 participants · Phase 2

    Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

  • NCT02610413 · 354 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer

  • NCT05729256 · 354 participants · NA

    Alcohol and "Heat of the Moment" Sexual Decision Making

  • NCT06507618 · 354 participants · Phase 3

    Pre-Operative Window of ET to Inform RT Decisions (POWER II)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03796065, the US trial registry maintained by the National Library of Medicine. NCT03796065 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.